Topic: Health & Lifestyle

HIV/AIDS: RV144 vaccine trial – what happens next?

Image Not Available

BANGKOK, 14 September 2011 (PlusNews) – Scientists could not explain how two infection-fighting proteins in humans affected the rate of HIV infection in participants of the vaccine trial in Thailand known as RV144 – until now. The six-year clinical trial was the first to produce evidence of an HIV vaccine that had shown some protective effect against HIV infection. Volunteers who received a vaccine combination were 31 percent less likely to be infected than those who did not, according to findings reported in 2009. Barton Haynes, from Duke University in the US, the coordinator of the follow-up study, said: “Without... Continue Reading

African Leaders charged to fund HIV vaccine research

Image Not Available

By: Ohemeng Tawiah, Bangkok, Thailand – African leaders are being challenged to commit themselves to the fight against HIV-AIDS by allocating more resources for research into finding a cure. An official of HIV Vaccine Trials Network, an international collaboration of scientists searching for effective and safe vaccines, says Africa should go beyond donor recipients to contributing positively to HIV vaccine research. Executive Director, Dr. James Kublin, says though the continent faces economic challenges, there is a lot Africa can offer if leadership demonstrates commitment. He spoke to Nhyira FM’s Ohemeng Tawiah at a training programme for journalists ahead of this... Continue Reading

South Africa: Clinical research essential element of healthcare reform

Image Not Available

Johannesburg, August 29, 2011 — The shortage of skilled clinical researchers is an important obstacle that will need to be addressed if reform of South Africa’s healthcare system is to be sustainable. “High quality clinical research, which requires a sound understanding of epidemiological and statistical methods, improves patient care because it provides insight and analysis of the causes, distribution, and control of diseases in local communities,” says Novartis Head of Global Development, US and Global Head Integrated Global Development Functions Group (IGDF), Dr Patrice Matchaba. “Because it provides scientifically valid answers to questions about diagnosis, prevention, therapy, prognosis and underlying causes of... Continue Reading

Tanzania: Dr Cooksey speaks on eradication of poverty

Image Not Available

By Elias Mhegera – PROPER management of resources and eradication of corruption could remove Tanzania from abject poverty very fast. This was a key statement from Dr Brian Cooksey of the Tanzania Development Research Group (TADREG). He was presenting his paper titled Governance and Rent Seeking in Tanzania: Beyond the Corruption Agenda? At British Council in a breakfast debate that was organized by the Policy Forum. Dr Cooksey a sociologist and seasoned researcher said that there is a big need for Tanzanians to change their attitudes in the way they handle serious matters. He asserted that the energy crisis going... Continue Reading

The IGPA is in Africa for the first time ever — breaking the barriers to medicine access!

Image Not Available

The conference provides the perfect platform for networking and interacting with emerging market companies and to learn about opportunities for immediate market entry. Delegates and exhibitors will have the opportunity to meet policy makers to understand how current and future policies may impact on their emerging market business strategies, and how they can best take advantage of these policy changes. If your company wants to play a key role in helping address Africa’s disease burden and enter the African pharmaceutical market, then you should attend the 14th Annual International Generic Pharmaceutical Alliance Conference in Cape Town, South Africa. The IGPA... Continue Reading